211 related articles for article (PubMed ID: 25592572)
1. Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
Kim D; Li R; Dudek SM; Wallace JR; Ritchie MD
Pac Symp Biocomput; 2015; ():96-107. PubMed ID: 25592572
[TBL] [Abstract][Full Text] [Related]
2. An integrated analysis of cancer genes in clear cell renal cell carcinoma.
Li J; Guo L; Ai Z
Future Oncol; 2017 Apr; 13(8):715-725. PubMed ID: 28266251
[TBL] [Abstract][Full Text] [Related]
3. Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.
Wei X; Choudhury Y; Lim WK; Anema J; Kahnoski RJ; Lane B; Ludlow J; Takahashi M; Kanayama HO; Belldegrun A; Kim HL; Rogers C; Nicol D; Teh BT; Tan MH
Sci Rep; 2017 Aug; 7(1):7342. PubMed ID: 28779136
[TBL] [Abstract][Full Text] [Related]
4. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression.
Marcon J; DiNatale RG; Sanchez A; Kotecha RR; Gupta S; Kuo F; Makarov V; Sandhu A; Mano R; Silagy AW; Blum KA; Nassau DE; Benfante NE; Ortiz MV; Carlo MI; Chan TA; Motzer RJ; Voss MH; Coleman J; Russo P; Reuter V; Hakimi AA; Reznik E
Clin Cancer Res; 2020 Jul; 26(14):3629-3640. PubMed ID: 32220885
[TBL] [Abstract][Full Text] [Related]
6. Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.
Hakimi AA; Mano R; Ciriello G; Gonen M; Mikkilineni N; Sfakianos JP; Kim PH; Motzer RJ; Russo P; Reuter VE; Hsieh JJ; Ostrovnaya I
J Urol; 2014 Jul; 192(1):24-9. PubMed ID: 24518768
[TBL] [Abstract][Full Text] [Related]
7. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma.
Kim JH; Jung CW; Cho YH; Lee J; Lee SH; Kim HY; Park J; Park JO; Kim K; Kim WS; Park YS; Im YH; Kang WK; Park K
Oncol Rep; 2005 May; 13(5):859-64. PubMed ID: 15809750
[TBL] [Abstract][Full Text] [Related]
8. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression.
Wang J; Xi J; Zhang H; Li J; Xia Y; Xi R; Xi Z
Cancer Commun (Lond); 2019 Jun; 39(1):37. PubMed ID: 31227023
[No Abstract] [Full Text] [Related]
10. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
[TBL] [Abstract][Full Text] [Related]
11. Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.
Liu K; Ren Y; Pang L; Qi Y; Jia W; Tao L; Hu Z; Zhao J; Zhang H; Li L; Yue H; Han J; Liang W; Hu J; Zou H; Yuan X; Li F
Int J Clin Exp Pathol; 2015; 8(7):8311-35. PubMed ID: 26339402
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma.
Li J; Guo L; Chai L; Ai Z
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830966. PubMed ID: 30852945
[TBL] [Abstract][Full Text] [Related]
13. Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes.
Zhong X; Yang H; Zhao S; Shyr Y; Li B
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S7. PubMed ID: 26099277
[TBL] [Abstract][Full Text] [Related]
14. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
Tokheim C; Bhattacharya R; Niknafs N; Gygax DM; Kim R; Ryan M; Masica DL; Karchin R
Cancer Res; 2016 Jul; 76(13):3719-31. PubMed ID: 27197156
[TBL] [Abstract][Full Text] [Related]
15. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
[TBL] [Abstract][Full Text] [Related]
16. Age-related somatic mutations in the cancer genome.
Milholland B; Auton A; Suh Y; Vijg J
Oncotarget; 2015 Sep; 6(28):24627-35. PubMed ID: 26384365
[TBL] [Abstract][Full Text] [Related]
17. NetNorM: Capturing cancer-relevant information in somatic exome mutation data with gene networks for cancer stratification and prognosis.
Le Morvan M; Zinovyev A; Vert JP
PLoS Comput Biol; 2017 Jun; 13(6):e1005573. PubMed ID: 28650955
[TBL] [Abstract][Full Text] [Related]
18. Discovery of mutated subnetworks associated with clinical data in cancer.
Vandin F; Clay P; Upfal E; Raphael BJ
Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
[TBL] [Abstract][Full Text] [Related]
19. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
20. Cancer subtype identification using somatic mutation data.
Kuijjer ML; Paulson JN; Salzman P; Ding W; Quackenbush J
Br J Cancer; 2018 May; 118(11):1492-1501. PubMed ID: 29765148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
